Latest filing published 18 Aug 2026 for Castle Biosciences INC, €643k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Frank Stokes on record concern Castle Biosciences Inc, in the capacity of finance chief. Between 14 September 2020 and 14 August 2026, the trades on record add up to 74 filings.
Every open-market trade on record is a sale: 28 sales worth €6.2M. Besides market trades, the filings include 19 share grants and 27 option exercises. 2026 to date brings no purchases and 4 sales.
On 18 August 2026 came the latest disclosure, an open-market sale for €643k in Castle Biosciences Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations